BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 31392723)

  • 1. Modulation of the functions of myeloid-derived suppressor cells : a new strategy of hydrogen sulfide anti-cancer effects.
    De Cicco P; Ercolano G; Rubino V; Terrazzano G; Ruggiero G; Cirino G; Ianaro A
    Br J Pharmacol; 2020 Feb; 177(4):884-897. PubMed ID: 31392723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hydrogen sulfide and dermatological diseases.
    Coavoy-Sánchez SA; Costa SKP; Muscará MN
    Br J Pharmacol; 2020 Feb; 177(4):857-865. PubMed ID: 31051046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visualization and quantification of
    Hoffmann SHL; Reck DI; Maurer A; Fehrenbacher B; Sceneay JE; Poxleitner M; Öz HH; Ehrlichmann W; Reischl G; Fuchs K; Schaller M; Hartl D; Kneilling M; Möller A; Pichler BJ; Griessinger CM
    Theranostics; 2019; 9(20):5869-5885. PubMed ID: 31534525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydrogen Sulfide Reduces Myeloid-Derived Suppressor Cell-Mediated Inflammatory Response in a Model of
    De Cicco P; Sanders T; Cirino G; Maloy KJ; Ianaro A
    Front Immunol; 2018; 9():499. PubMed ID: 29636751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myeloid-derived Suppressor Cells Elimination by 5-Fluorouracil Increased Dendritic Cell-based Vaccine Function and Improved Immunity in Tumor Mice.
    Khosravianfar N; Hadjati J; Namdar A; Boghozian R; Hafezi M; Ashourpour M; Kheshtchin N; Banitalebi M; Mirzaei R; Razavi SA
    Iran J Allergy Asthma Immunol; 2018 Feb; 17(1):47-55. PubMed ID: 29512369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 6-Thioguanine-loaded polymeric micelles deplete myeloid-derived suppressor cells and enhance the efficacy of T cell immunotherapy in tumor-bearing mice.
    Jeanbart L; Kourtis IC; van der Vlies AJ; Swartz MA; Hubbell JA
    Cancer Immunol Immunother; 2015 Aug; 64(8):1033-46. PubMed ID: 25982370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prim-O-glucosylcimifugin enhances the antitumour effect of PD-1 inhibition by targeting myeloid-derived suppressor cells.
    Gao W; Zhang X; Yang W; Dou D; Zhang H; Tang Y; Zhong W; Meng J; Bai Y; Liu Y; Yang L; Chen S; Liu H; Yang C; Sun T
    J Immunother Cancer; 2019 Aug; 7(1):231. PubMed ID: 31462297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunosuppression mediated by myeloid-derived suppressor cells (MDSCs) during tumour progression.
    Groth C; Hu X; Weber R; Fleming V; Altevogt P; Utikal J; Umansky V
    Br J Cancer; 2019 Jan; 120(1):16-25. PubMed ID: 30413826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The New Era of Cancer Immunotherapy: Targeting Myeloid-Derived Suppressor Cells to Overcome Immune Evasion.
    De Cicco P; Ercolano G; Ianaro A
    Front Immunol; 2020; 11():1680. PubMed ID: 32849585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maitake α-glucan promotes differentiation of monocytic myeloid-derived suppressor cells into M1 macrophages.
    Masuda Y; Nakayama Y; Shimizu R; Naito K; Miyamoto E; Tanaka A; Konishi M
    Life Sci; 2023 Mar; 317():121453. PubMed ID: 36709912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting myeloid-derived suppressor cells using all-trans retinoic acid in melanoma patients treated with Ipilimumab.
    Tobin RP; Jordan KR; Robinson WA; Davis D; Borges VF; Gonzalez R; Lewis KD; McCarter MD
    Int Immunopharmacol; 2018 Oct; 63():282-291. PubMed ID: 30121453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydrogen sulfide inhibits calcification of heart valves; implications for calcific aortic valve disease.
    Sikura KÉ; Potor L; Szerafin T; Oros M; Nagy P; Méhes G; Hendrik Z; Zarjou A; Agarwal A; Posta N; Torregrossa R; Whiteman M; Fürtös I; Balla G; Balla J
    Br J Pharmacol; 2020 Feb; 177(4):793-809. PubMed ID: 31017307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel and enhanced anti-melanoma DNA vaccine targeting the tyrosinase protein inhibits myeloid-derived suppressor cells and tumor growth in a syngeneic prophylactic and therapeutic murine model.
    Yan J; Tingey C; Lyde R; Gorham TC; Choo DK; Muthumani A; Myles D; Weiner LP; Kraynyak KA; Reuschel EL; Finkel TH; Kim JJ; Sardesai NY; Ugen KE; Muthumani K; Weiner DB
    Cancer Gene Ther; 2014 Dec; 21(12):507-17. PubMed ID: 25394503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signalling by hydrogen sulfide and polysulfides via protein S-sulfuration.
    Kimura H
    Br J Pharmacol; 2020 Feb; 177(4):720-733. PubMed ID: 30657595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myeloid-Derived Suppressor Cells Express Bruton's Tyrosine Kinase and Can Be Depleted in Tumor-Bearing Hosts by Ibrutinib Treatment.
    Stiff A; Trikha P; Wesolowski R; Kendra K; Hsu V; Uppati S; McMichael E; Duggan M; Campbell A; Keller K; Landi I; Zhong Y; Dubovsky J; Howard JH; Yu L; Harrington B; Old M; Reiff S; Mace T; Tridandapani S; Muthusamy N; Caligiuri MA; Byrd JC; Carson WE
    Cancer Res; 2016 Apr; 76(8):2125-36. PubMed ID: 26880800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydrogen sulfide regulates muscle RING finger-1 protein S-sulfhydration at Cys
    Sun X; Zhao D; Lu F; Peng S; Yu M; Liu N; Sun Y; Du H; Wang B; Chen J; Dong S; Lu F; Zhang W
    Br J Pharmacol; 2020 Feb; 177(4):836-856. PubMed ID: 30734268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autophagy orchestrates the regulatory program of tumor-associated myeloid-derived suppressor cells.
    Alissafi T; Hatzioannou A; Mintzas K; Barouni RM; Banos A; Sormendi S; Polyzos A; Xilouri M; Wielockx B; Gogas H; Verginis P
    J Clin Invest; 2018 Aug; 128(9):3840-3852. PubMed ID: 29920188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapy Targeting Myeloid-Derived Suppressor Cells (MDSCs) in Tumor Microenvironment.
    Gao X; Sui H; Zhao S; Gao X; Su Y; Qu P
    Front Immunol; 2020; 11():585214. PubMed ID: 33613512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting myeloid-derived suppressor cells with gemcitabine to enhance efficacy of adoptive cell therapy in bladder cancer.
    Bazargan S; Bunch B; Ojwang' AME; Blauvelt J; Landin A; Ali J; Abrahams D; Cox C; Hall AM; Beatty MS; Poch M; Rejniak KA; Pilon-Thomas S
    Front Immunol; 2023; 14():1275375. PubMed ID: 37901214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel methodology of the myeloid-derived suppressor cells (MDSCs) generation with splenic stroma feeder cells.
    Tian F; Jiang P; Wu M; Xing Y; Liu L; Dai X; Tang H; Yang ZF; Wang L; Zhu X
    Exp Cell Res; 2020 Sep; 394(2):112119. PubMed ID: 32485182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.